Re: Thanks
|
2
|
Resverlogix Corp.
|
May 12, 2021 10:18AM
|
Re: Test run of posting the coming presentation
|
|
Resverlogix Corp.
|
Nov 16, 2019 11:15AM
|
Re: Test run of posting the coming presentation
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 11:24AM
|
Re: Test run of posting the coming presentation
|
|
Resverlogix Corp.
|
Nov 16, 2019 11:55AM
|
Re: Tempted but....
|
1
|
Resverlogix Corp.
|
Aug 19, 2021 07:58AM
|
Re: Technically we're very oversold...
|
1
|
Resverlogix Corp.
|
Dec 17, 2019 02:28PM
|
Re: Technically we're very oversold...
|
1
|
Resverlogix Corp.
|
Dec 17, 2019 03:44PM
|
Re: Technically we're very oversold...
|
|
Resverlogix Corp.
|
Dec 17, 2019 04:33PM
|
Re: Technical strength versus fundamental weakness....
|
2
|
Resverlogix Corp.
|
Mar 31, 2019 03:12PM
|
Re: Technical strength versus fundamental weakness....
|
4
|
Resverlogix Corp.
|
Mar 31, 2019 04:43PM
|
Re: Technical strength versus fundamental weakness....
|
1
|
Resverlogix Corp.
|
Mar 31, 2019 07:48PM
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
6
|
Zenith Epigenetics
|
Aug 20, 2020 08:14AM
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
1
|
Zenith Epigenetics
|
Oct 20, 2020 08:38AM
|
Re: TD Zenith Capital Corp | Grey Market : ZENI.P
|
1
|
Zenith Epigenetics
|
Oct 20, 2020 08:42AM
|
Re: TD Ameritrade
|
1
|
Zenith Epigenetics
|
Mar 14, 2023 03:54PM
|
Re: Tax strategy question for Canadian!
|
2
|
Resverlogix Corp.
|
Oct 25, 2020 03:52PM
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
1
|
Resverlogix Corp.
|
Aug 29, 2019 11:12AM
|
Re: Talk about getting.....
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 12:35PM
|
Re: Surprising.....
|
1
|
Resverlogix Corp.
|
Oct 01, 2019 10:34AM
|
Re: Surprise
|
1
|
Resverlogix Corp.
|
Nov 29, 2019 12:11PM
|